Continuous Glucose Monitoring Integration for Remote Diabetes Management: Virtual Diabetes Care with Case Studies

被引：14
作者：
Carlson, Anders L. [1 ,2 ]
Martens, Thomas W. [3 ]
Johnson, Libby [4 ]
Criego, Amy B. [5 ]
机构：
[1] HealthPartners Clin, Int Diabet Ctr, 3800 Pk Nicollet Blvd, Minneapolis, MN 55416 USA
[2] Univ Minnesota, Sch Med, Stillwater Med Grp, Adult Endocrinologist HealthPartners, Minneapolis, MN USA
[3] Pk Nicollet Clin, Internal Med, Int Diabet Ctr, Minneapolis, MN USA
[4] Int Diabet Ctr, St Louis Pk, MN USA
[5] Pk Nicollet Clin, Pediat Endocrinol, Int Diabet Ctr, Minneapolis, MN USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2021年 / 23卷
关键词：
CGM; Telemedicine; Ambulatory Glucose Profile; Type; 1; diabetes; Remote monitoring; HEMOGLOBIN; SYSTEMS; PROFILE;
D O I：
10.1089/dia.2021.0241
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Use of telemedicine and remote monitoring technologies can significantly improve glycemic control in patients with type 1 diabetes and type 2 diabetes. Patients' ability to interact remotely with their health care providers via smartphones and other communication devices can increase their access to clinical care and online coaching and support programs. The establishment of metrics for clinical use of continuous glucose monitoring data and standardization of data reporting has enabled clinicians to maintain high-quality diabetes care through remote monitoring and telemedicine visits during the COVID-19 pandemic. This article discusses our experiences using remote monitoring and telemedicine visits during this time.
引用
收藏
页码：S56 / S65
页数：10
相关论文
共 25 条
  • [1] [Anonymous], 2014, BRIT J DIABETES VASC, DOI [10.15277/bjdvd.2014.045, DOI 10.15277/bjdvd.2014.045]
  • [2] Remote Application and Use of Real-Time Continuous Glucose Monitoring by Adults with Type 2 Diabetes in a Virtual Diabetes Clinic
    Bergenstal, Richard M.
    Layne, Jennifer E.
    Zisser, Howard
    Gabbay, Robert A.
    Barleen, Nathan A.
    Lee, Amy Armento
    Majithia, Amit R.
    Parkin, Christopher G.
    Dixon, Ronald F.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (02) : 128 - 132
  • [3] Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring
    Bergenstal, Richard M.
    Beck, Roy W.
    Close, Kelly L.
    Grunberger, George
    Sacks, David B.
    Kowalski, Aaron
    Brown, Adam S.
    Heinemann, Lutz
    Aleppo, Grazia
    Ryan, Donna B.
    Riddlesworth, Tonya D.
    Cefalu, William T.
    [J]. DIABETES CARE, 2018, 41 (11) : 2275 - 2280
  • [4] Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP)
    Bergenstal, Richard M.
    Ahmann, Andrew J.
    Bailey, Timothy
    Beck, Roy W.
    Bissen, Joan
    Buckingham, Bruce
    Deeb, Larry
    Dolin, Robert H.
    Garg, Satish K.
    Goland, Robin
    Hirsch, Irl B.
    Klonoff, David C.
    Kruger, Davida F.
    Matfin, Glenn
    Mazze, Roger S.
    Olson, Beth A.
    Parkin, Christopher
    Peters, Anne
    Powers, Margaret A.
    Rodriguez, Henry
    Southerland, Phil
    Strock, Ellie S.
    Tamborlane, William
    Wesley, David M.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 (03) : 198 - 211
  • [5] Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown
    Boscari, Federico
    Ferretto, Sara
    Uliana, Ambra
    Avogaro, Angelo
    Bruttomesso, Daniela
    [J]. NUTRITION & DIABETES, 2021, 11 (01)
  • [6] Bry L, 2001, CLIN CHEM, V47, P153
  • [7] Improvement in Psychosocial Outcomes in Children with Type 1 Diabetes and Their Parents Following Subsidy for Continuous Glucose Monitoring
    Burckhardt, Marie-Anne
    Abraham, Mary B.
    Mountain, Jennifer
    Coenen, Daina
    Paniora, Jaimee
    Clapin, Helen
    Jones, Timothy W.
    Davis, Elizabeth A.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (10) : 575 - 580
  • [8] The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic Patients A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study)
    Charpentier, Guillaume
    Benhamou, Pierre-Yves
    Dardari, Dured
    Clergeot, Annie
    Franc, Sylvia
    Schaepelynck-Belicar, Pauline
    Catargi, Bogdan
    Melki, Vincent
    Chaillous, Lucy
    Farret, Anne
    Bosson, Jean-Luc
    Penfornis, Alfred
    [J]. DIABETES CARE, 2011, 34 (03) : 533 - 539
  • [9] When HbA1c and Blood Glucose Do Not Match: How Much Is Determined by Race, by Genetics, by Differences in Mean Red Blood Cell Age?
    Cohen, Robert M.
    Franco, Robert S.
    Smith, Eric P.
    Higgins, John M.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (03) : 707 - 710
  • [10] A Virtual Type 2 Diabetes Clinic Using Continuous Glucose Monitoring and Endocrinology Visits
    Dixon, Ronald F.
    Zisser, Howard
    Layne, Jennifer E.
    Barleen, Nathan A.
    Miller, David P.
    Moloney, Daniel P.
    Majithia, Amit R.
    Gabbay, Robert A.
    Riff, Josh
    [J]. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2020, 14 (05): : 908 - 911
123